Physician profile
Scott M Bortman
NPI 1518940568
$30,715.82
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $399.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,076.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10,414.20 | 2019 | |
| Boston Scientific Corporation | $3,381.36 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $3,299.17 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $1,454.94 | 2019 | |
| Amgen INC. | $203.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $191.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $150.18 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $98.07 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.68 | 2019 | |
| Bardy Diagnostics, INC. | $76.00 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $66.01 | 2020 | |
| Amarin Pharma, INC. | $58.92 | 2019 | |
| Gilead Sciences, INC. | $40.26 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $30.48 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $22.03 | 2020 | |
| Sanofi Pasteur INC. | $21.19 | 2020 | |
| Lilly USA, LLC | $19.35 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $16.63 | 2019 | |
| Medtronic Vascular, INC. | $14.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bortman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.